A case of sporadic hemiplegic migraine treated with eptinezumab: should we consider anti-CGRP antibodies for selected patients?

Neurol Sci. 2025 Jan 2. doi: 10.1007/s10072-024-07980-0. Online ahead of print.

Pietro Antenucci¹, Federica Pes², Edward Cesnik³, Jay Guido Capone^{3

4}, Marina Padroni^{3

4}

¹ Unit of Clinical Neurology, Neurosciences and Rehabilitation Department, University of Ferrara, Via Aldo Moro 8, Cona, Ferrara, 44121, Italy. [email protected].
² Unit of Clinical Neurology, Neurosciences and Rehabilitation Department, University of Ferrara, Via Aldo Moro 8, Cona, Ferrara, 44121, Italy.
³ Neurology Unit, Neurosciences and Rehabilitation Department, Ferrara University Hospital, Ferrara, 44124, Italy.
⁴ Headache outpatient clinic, Neurology Unit, Ferrara University Hospital, Ferrara, 44124, Italy.

No abstract available

Publication types